Literature DB >> 27022025

Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity.

Agnes Czikora1, Daniel J Lundberg2, Adelle Abramovitz1, Nancy E Lewin1, Noemi Kedei1, Megan L Peach3, Xiaoling Zhou1, Raymond C Merritt2, Elizabeth A Craft2, Derek C Braun2, Peter M Blumberg4.   

Abstract

The C1 domain represents the recognition module for diacylglycerol and phorbol esters in protein kinase C, Ras guanine nucleotide releasing protein (RasGRP), and related proteins. RasGRP2 is exceptional in that its C1 domain has very weak binding affinity (Kd = 2890 ± 240 nm for [(3)H]phorbol 12,13-dibutyrate. We have identified four amino acid residues responsible for this lack of sensitivity. Replacing Asn(7), Ser(8), Ala(19), and Ile(21) with the corresponding residues from RasGRP1/3 (Thr(7), Tyr(8), Gly(19), and Leu(21), respectively) conferred potent binding affinity (Kd = 1.47 ± 0.03 nm) in vitro and membrane translocation in response to phorbol 12-myristate 13-acetate in LNCaP cells. Mutant C1 domains incorporating one to three of the four residues showed intermediate behavior with S8Y making the greatest contribution. Binding activity for diacylglycerol was restored in parallel. The requirement for anionic phospholipid for [(3)H]phorbol 12,13-dibutyrate binding was determined; it decreased in going from the single S8Y mutant to the quadruple mutant. The full-length RasGRP2 protein with the mutated C1 domains also showed strong phorbol ester binding, albeit modestly weaker than that of the C1 domain alone (Kd = 8.2 ± 1.1 nm for the full-length protein containing all four mutations), and displayed translocation in response to phorbol ester. RasGRP2 is a guanyl exchange factor for Rap1. Consistent with the ability of phorbol ester to induce translocation of the full-length RasGRP2 with the mutated C1 domain, phorbol ester enhanced the ability of the mutated RasGRP2 to activate Rap1. Modeling confirmed that the four mutations helped the binding cleft maintain a stable conformation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  C1 domain; Ras-related protein 1 (Rap1); RasGRP2; cloning; guanine nucleotide exchange factor (GEF); phorbol ester; protein kinase C (PKC)

Mesh:

Substances:

Year:  2016        PMID: 27022025      PMCID: PMC4900263          DOI: 10.1074/jbc.M116.725333

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.

Authors:  Q J Wang; T W Fang; K Nacro; V E Marquez; S Wang; P M Blumberg
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

Review 3.  Rationally designed peptide regulators of protein kinase C.

Authors:  Eric N Churchill; Nir Qvit; Daria Mochly-Rosen
Journal:  Trends Endocrinol Metab       Date:  2008-12-04       Impact factor: 12.015

4.  Synthesis and phorbol ester binding of the cysteine-rich domains of diacylglycerol kinase (DGK) isozymes. DGKgamma and DGKbeta are new targets of tumor-promoting phorbol esters.

Authors:  Mayumi Shindo; Kazuhiro Irie; Akiko Masuda; Hajime Ohigashi; Yasuhito Shirai; Kei Miyasaka; Naoaki Saito
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

Review 5.  CalDAG-GEFI and platelet activation.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  Platelets       Date:  2010       Impact factor: 3.862

6.  Probing the determinants of diacylglycerol binding affinity in the C1B domain of protein kinase Cα.

Authors:  Mikaela D Stewart; Brittany Morgan; Francesca Massi; Tatyana I Igumenova
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

7.  Toward the identification of selective modulators of protein kinase C (PKC) isozymes: establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and identification of the critical residues involved in the phorbol ester binding.

Authors:  M Shindo; K Irie; A Nakahara; H Ohigashi; H Konishi; U Kikkawa; H Fukuda; P A Wender
Journal:  Bioorg Med Chem       Date:  2001-08       Impact factor: 3.641

8.  Charge density influences C1 domain ligand affinity and membrane interactions.

Authors:  Jessica S Kelsey; Tamas Geczy; Nancy E Lewin; Noemi Kedei; Colin S Hill; Julia S Selezneva; Christopher J Valle; Wonhee Woo; Inna Gorshkova; Peter M Blumberg
Journal:  Chembiochem       Date:  2014-04-28       Impact factor: 3.164

9.  Biochemical characterization of hyperactive beta2-chimaerin mutants revealed an enhanced exposure of C1 and Rac-GAP domains.

Authors:  Maria Soledad Sosa; Nancy E Lewin; Sung-Hee Choi; Peter M Blumberg; Marcelo G Kazanietz
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

10.  Interactions of protein kinase C-α C1A and C1B domains with membranes: a combined computational and experimental study.

Authors:  Jianing Li; Brian P Ziemba; Joseph J Falke; Gregory A Voth
Journal:  J Am Chem Soc       Date:  2014-08-11       Impact factor: 15.419

View more
  11 in total

1.  Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.

Authors:  Agnes Czikora; Satyabrata Pany; Youngki You; Amandeep S Saini; Nancy E Lewin; Gary A Mitchell; Adelle Abramovitz; Noemi Kedei; Peter M Blumberg; Joydip Das
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-01-06       Impact factor: 3.747

2.  Calcium-induced structural rearrangements release autoinhibition in the Rap-GEF CalDAG-GEFI.

Authors:  Aaron A Cook; Wei Deng; Jinqi Ren; Renhao Li; John Sondek; Wolfgang Bergmeier
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 3.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

4.  The C1 domain of Vav3, a novel potential therapeutic target.

Authors:  Jessica S Kelsey; Tamás Géczy; Christopher J Kaler; Peter M Blumberg
Journal:  Cell Signal       Date:  2017-09-18       Impact factor: 4.315

Review 5.  Protein kinase C in cancer: The top five unanswered questions.

Authors:  Mariana Cooke; Andrew Magimaidas; Victoria Casado-Medrano; Marcelo G Kazanietz
Journal:  Mol Carcinog       Date:  2017-03-10       Impact factor: 4.784

6.  Critical Role of Trp-588 of Presynaptic Munc13-1 for Ligand Binding and Membrane Translocation.

Authors:  Joydip Das; Noemi Kedei; Jessica S Kelsey; Youngki You; Satyabrata Pany; Gary A Mitchell; Nancy E Lewin; Peter M Blumberg
Journal:  Biochemistry       Date:  2018-01-05       Impact factor: 3.162

7.  Subcellular localization of Rap1 GTPase activator CalDAG-GEFI is orchestrated by interaction of its atypical C1 domain with membrane phosphoinositides.

Authors:  Muzaddid Sarker; Ardeshir Goliaei; Florence Golesi; Marjorie Poggi; Aaron A Cook; Mohammad A I Khan; Brenda R Temple; Lucia Stefanini; Matthias Canault; Wolfgang Bergmeier; Sharon L Campbell
Journal:  J Thromb Haemost       Date:  2019-12-30       Impact factor: 5.824

Review 8.  RAP GTPases and platelet integrin signaling.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  Platelets       Date:  2018-06-04       Impact factor: 3.862

9.  The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T Cells.

Authors:  Jana Niemz; Stefanie Kliche; Marina C Pils; Eliot Morrison; Annika Manns; Christian Freund; Jill R Crittenden; Ann M Graybiel; Melanie Galla; Lothar Jänsch; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-05-22

10.  Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells.

Authors:  Kanika Vanshylla; Caren Bartsch; Christoffer Hitzing; Laura Krümpelmann; Jürgen Wienands; Niklas Engels
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.